Introduction
============

Primary salivary gland-type tumors of the lung are rare and include mucoepidermoid carcinoma, adenoid cystic carcinoma, acinic cell carcinoma, oncocytoma, epithelial-myoepithelial carcinoma, benign myoepithelioma, and mixed tumors of both benign and malignant nature \[[@B1]-[@B16]\]. Primary pulmonary myoepithelial carcinomas are exceedingly rare, with only five known prior cases reported in the English literature to date \[[@B17]-[@B20]\]. We report a case of primary myoepithelial carcinoma of the lung and a review of the literature.

Case Report
===========

A 63-year-old woman presented to the clinic with a history of increasing pulmonary congestion, difficulty expectorating, and low-grade hemoptysis. Her past medical history was significant for diet-controlled insulin-dependent diabetes mellitus. There was no history of cigarette or other tobacco use. Her mother had died of breast cancer in her fifties. A chest radiograph showed a large mass in the right lower lung fields, and computed tomography scanning revealed a 12.4 × 8.3 centimeter smoothly circumscribed heterogeneous mass arising in the right minor fissure and impinging upon the right atrium (Figure [1A](#F1){ref-type="fig"}). A fine needle aspiration was performed which yielded a diagnosis initially suspicious for schwannoma, as reviewed at an outside institution. At the time of thoracotomy, dense adhesions were dissected free of the upper and middle lobes with no evidence of tumor invasion, and the mass was resected en-bloc with pericardium and a wedge resection of the lower lobe. An additional separate lower lobe nodule was also excised and presumed to be a metastatic focus of tumor. The patient had an uneventful recovery and was discharged home on post-operative day number three.

![**Radiographic and gross pathologic appearance of primary pulmonary myoepithelial carcinoma**. **A**. Computed tomography of right-sided chest mass with compression of right atrium. **B.** Gross pathologic appearance of right visceral pleural mass.](1749-8090-6-27-1){#F1}

The patient developed a biopsy proven solitary liver/diaphragmatic metastasis diagnosed on routine follow-up at 36 months post-resection.

Pathologic Findings
===================

Gross pathologic examination revealed the mass to be a 13 × 8 × 8 centimeter lower lobe carcinoma of myoepithelial origin involving the visceral pleura (Figure [1B](#F1){ref-type="fig"}).

Histologically, the mass was consistent with a malignant myoepithelial neoplasm with a fibrous capsule and 20% necrosis. The mass was thought to arise from the right lower lobe and involved the visceral pleura. The margin was focally within 0.1 cm of the tumor, but otherwise grossly free of invasion. The separate nodule was 1 cm in size and histologically similar to the primary tumor.

Immunohistochemical stains were performed and were focally positive for AE1/AE3, Bcl2, Cam5.2, S100p, GFAP, 4A4, SMA, and CD99. Stains for EMA, desmin, CD34, calponin, FLI1, myogenin, and synaptophysin were negative.

Discussion
==========

Myoepithelial carcinomas primarily arise from the salivary glands, the parotid, or the breast \[[@B21]\]. Rarely, they may arise in soft tissues, most often in the lower and upper limbs, occurring equally in men and women \[[@B22]\]. These soft-tissue tumors, distinguished from benign myoepitheliomas by their moderate or severe cytologic atypia or invasive growth pattern, recur locally in 42% of patients and metastasize to distant sites in 32%.

Primary myoepithelial carcinomas of the lung are exceedingly rare, with only 6 patients reported in the English literature, including the present report \[[@B17]-[@B20]\]. Clinical data from these reports are summarized in Table [1](#T1){ref-type="table"}. Very limited information was available for one patient \[[@B20]\]. Most patients were male, in their fifth or sixth decade of life at diagnosis, and smoked tobacco. Most patients presented with primarily endobronchial disease, had preoperative biopsies of their tumors, and underwent anatomic resections of these malignancies. There were no local recurrences. Almost all patients had metastatic disease, either synchronous at time of resection, or presenting as metachronous recurrence. Follow-up was less than two years for all but one patient, who died of metastatic disease to the liver five years postoperatively. One other patient died at fourteen months from synchronous metastatic adenocarcinoma. One patient was alive with disease, and two others were free of disease at relatively short follow-up intervals.

###### 

Clinical characteristics of reported cases of myoepithelial carcinoma of the lung.

  AUTHOR             Age/Sex   Smoking   Location                                      Pre-op Bx Diagnosis                              Size (cm)   Resection Type                 Local Recurrence   Metastasis                                                       Outcome
  ------------------ --------- --------- --------------------------------------------- ------------------------------------------------ ----------- ------------------------------ ------------------ ---------------------------------------------------------------- ----------------------------------------------------------
  Present case       63F       No        RLL, Pleural & parenchymal                    Low grade spindle cell neoplasm                  13.0        Wedge/Local excision           No                 Yes, same lobe/pleura at time of resection, liver at 36 months   AWD at 36 months
                                                                                                                                                                                                                                                                       
  Masuya 2005        48M       Yes       LLL, Parenchymal & Endobronchial              Sarcoma, sarcomatoid carcinoma, carcinosarcoma   1.5         Lobectomy                      No                 No                                                               NED 15 months
                                                                                                                                                                                                                                                                       
  Miura 2000         46M       NA        Right hilum, Right Main Stem, Endobronchial   No atypical cells                                6.5         Pneumonectomy                  No                 Yes, LLL                                                         AWD at 7 months
                                                                                                                                                                                                                                                                       
  Higashiyama        58M       Yes       RUL, Endobronchial                            NA                                               3.8         Sleeve bilobectomy (RUL/RML)   No                 Yes, soft tissue left arm and hip                                DOC at 14 months (metastatic synchronous adenocarcinoma)
                                                                                                                                                                                                                                                                       
  Higashiyama 1998   58M       Yes       LUL, Endobronchial                            Squamous cell carcinoma                          6.0         Sleeve lobectomy (LUL)         No                 Yes, liver                                                       DOD, 60 months
                                                                                                                                                                                                                                                                       
  Sekine 1998        NA        NA        NA                                            NA                                               NA          NA                             NA                 Yes                                                              NA

RLL - right lower lobe; LLL - left lower lobe; RUL - right upper lobe; LUL - left upper lobe; RML - right middle lobe; Bx - biopsy; NED - no evidence of disease; AWD - alive with disease; DOC - dead of other causes; DOD - dead of disease

Given the available reported data, there are a number of unique characteristics of the current case when compared to the previous five. This case represents the eldest and only female patient, as well as the only known never-smoker. This patient\'s tumor is also the greatest in size within this series, more than doubling the previous known largest of these tumors. All other patients in the series presented with a major component of endobronchial disease, whereas the current tumor was primarily pleural/parenchymal based. Finally, the current case represents the only patient treated with a limited sub-anatomic resection.

Given the relatively high rates of recurrence, low-grade malignant status, and the propensity for recurrence at distant sites, it is reasonable to consider limited sub-anatomic, parenchymal sparing resections for these patients, especially if pneumonectomy is contemplated. While this may not be adequate for endobronchial lesions involving major pulmonary segments, it is feasible for lesions presenting with primarily parenchymal or pleural based disease, as in the current case. Given the rarity of these tumors, recommendations regarding chemotherapy or radiation, either pre- or postoperatively, are difficult to formulate.
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